ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction

European Journal of Cancer

Volumn 46, Issue 9, 2010, Pages 1712-1723

  Tsai, Sen Tien ^a,b   Chien, I Hsiu ^c   Shen, Wen Hao ^c   Kuo, Yi Zih ^c   Jin, Ying Tai ^a,c   Wong, Tung Yiu ^c   Hsiao, Jenn Ren ^a   Wang, Hsing Ping ^c   Shih, Neng Yao ^d   Wu, Li Wha ^c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Tainan Hospital   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

CCL20; ENO1; Enolase; Glycolysis; Head and neck cancer

Indexed keywords

ENOLASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; PROTEIN ENO1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENO1 PROTEIN, HUMAN; RNA; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NECK METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; ANIMAL; ENZYMOLOGY; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE TUMOR; TUMOR CELL CULTURE; TUMOR INVASION; UPREGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CCL20; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 77952584341     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.03.018     Document Type: Article

References (35)

1. Jin S., DiPaola R.S., Mathew R., and White E. Metabolic catastrophe as a means to cancer cell death. J Cell Sci 120 Pt 3 (2007) 379-383
2. Mankoff D.A., Dunnwald L.K., Partridge S.C., and Specht J.M. Blood flow-metabolism mismatch: good for the tumor, bad for the patient. Clin Cancer Res 15 17 (2009) 5294-5296
3. Brahimi-Horn C., and Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer 93 8 (2006) E73-E80
4. Altenberg B., and Greulich K.O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84 6 (2004) 1014-1020
5. Kim J.W., and Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30 3 (2005) 142-150
6. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58 7 (2001) 902-920
7. Miles L.A., Dahlberg C.M., Plescia J., et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30 6 (1991) 1682-1691
8. Dano K., Behrendt N., Hoyer-Hansen G., et al. Plasminogen activation and cancer. Thromb Haemost 93 4 (2005) 676-681
9. Wygrecka M, Marsh LM, Morty RE, et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009;113(22):5588-98 [Epub 30th January 2009].
10. Liu K.-J., and Shih N.-Y. The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. J Cancer Mol 3 2 (2007) 45-48
11. Hamaguchi T., Iizuka N., Tsunedomi R., et al. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 33 4 (2008) 725-731
12. Racz A., Brass N., Hofer M., et al. Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma. Int J Oncol 17 1 (2000) 67-73
13. Semenza G.L., Jiang B.H., Leung S.W., et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271 51 (1996) 32529-32537
14. Osthus R.C., Shim H., Kim S., et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275 29 (2000) 21797-21800
15. Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin Cancer Res 2003;9(10 Pt 1):3641-4.
16. Ejeskar K., Krona C., Caren H., et al. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5 (2005) 161
17. Chang G.C., Liu K.J., Hsieh C.L., et al. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 12 19 (2006) 5746-5754
18. He P., Naka T., Serada S., et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98 8 (2007) 1234-1240
19. Wu W., Tang X., Hu W., et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19 4 (2002) 319-326
20. Deshpande A.M., and Wong D.T. Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther 8 5 (2008) 799-809
21. Tsantoulis P.K., Kastrinakis N.G., Tourvas A.D., Laskaris G., and Gorgoulis V.G. Advances in the biology of oral cancer. Oral Oncol 43 6 (2007) 523-534
22. Ito S., Honma T., Ishida K., et al. Differential expression of the human alpha-enolase gene in oral epithelium and squamous cell carcinoma. Cancer Sci 98 4 (2007) 499-505
23. Tsai W.C., Tsai S.T., Jin Y.T., and Wu L.W. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol Cancer Res 4 8 (2006) 539-547
24. Abiko Y., Nishimura M., Kusano K., et al. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma. Arch Oral Biol 48 2 (2003) 171-175
25. Kleeff J., Kusama T., Rossi D.L., et al. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 81 4 (1999) 650-657
26. Campbell A.S., Albo D., Kimsey T.F., White S.L., and Wang T.N. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. J Surg Res 123 1 (2005) 96-101
27. Fujii H., Itoh Y., Yamaguchi K., et al. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro. Biochem Biophys Res Commun 322 3 (2004) 1052-1058
28. Chang K.P., Hao S.P., Chang J.H., et al. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res 14 21 (2008) 6979-6987
29. Subramanian A, Miller DM. Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 2000;275(8):5958-65.
30. Takashima M., Kuramitsu Y., Yokoyama Y., et al. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5 6 (2005) 1686-1692
31. Borrello M.G., Degl'Innocenti D., and Pierotti M.A. Inflammation and cancer: the oncogene-driven connection. Cancer Lett 267 2 (2008) 262-270
32. Ancrile B.B., O'Hayer K.M., and Counter C.M. Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics. Mol Interv 8 1 (2008) 22-27
33. Singh S., Sadanandam A., and Singh R.K. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 26 3-4 (2007) 453-467
34. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14 5 (2003) 409-426
35. Rubie C., Frick V.O., Wagner M., et al. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol 63 6 (2006) 468-477